The miRNA-mediated Translational De-suppression in Hypoxic Endothelium
缺氧内皮细胞中 miRNA 介导的翻译去抑制
基本信息
- 批准号:8716847
- 负责人:
- 金额:$ 22.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-21 至 2015-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): MicroRNAs (miRNAs) are non-coding small RNAs that regulate gene expression at the post- transcriptional level. Ranging from 18 to 24 nt (22 nt in general), miRNAs regulate gene expression by suppressing protein translation of target mRNAs or enhancing their degradation. miRNAs targeting mRNAs depends on the association of the miRNA/mRNA complex with Argonaute (Ago) endonuclease to form the miRNA-induced silencing complex (miRISC). We used sequencing by synthesis (SBS) deep sequencing to study the miRNAs in cultured vascular endothelial cells (ECs) exposed to hypoxia and bioinformatics approaches to analyze the hypoxia-responsive miRNAs at the genome-wide scale. Among miRNAs with greatly changed expression, Let-7s and miR-103/107 target Ago1. This result suggests that a "miRNA- mediated translational de-suppression" mechanism may occur in ECs under hypoxia. With these data acquired from high-throughput screening and in silico approaches, two specific aims are proposed to test the hypothesis that under hypoxia, the increased Let-7s and miR-103/107 down-regulate Ago1. Such a suppression of Ago1 decreases miRISC-mediated miRNA targeting and hence up-regulates targeted mRNAs, which encode highly translated proteins in ECs responding to hypoxia. Specific Aim 1 will study the Ago1- regulated miRNA/mRNA targeting in ECs responding to hypoxia. We will use Ago1 cross-linking immunoprecipitation sequencing (CLIP-seq) to profile the miRISC-associated miRNAs and their mRNA targets in ECs under normoxia and hypoxia. Specific Aim 2 will decipher the functional consequences of the miRNA- mediated translational de-suppression in cultured ECs and mouse hindlimb. Specifically, we will manipulate the expression of Let-7s and miR-103/107 in vitro and in vivo. The miRISC-mediated miRNA/mRNA targeting and mRNA-encoded proteins under normoxia and hypoxia will be examined. The elucidated mechanism will reveal mechanistic insights underlying the miRNA-regulated gene expression in ECs in response to hypoxia.
描述(由申请人提供):微小RNA(miRNA)是在转录后水平调节基因表达的非编码小RNA。范围从18到24 nt(一般为22 nt),miRNA通过抑制靶mRNA的蛋白质翻译或增强其降解来调节基因表达。靶向mRNA的miRNA依赖于miRNA/mRNA复合物与Argonaute(Ago)核酸内切酶的结合以形成miRNA诱导的沉默复合物(miRISC)。我们使用合成测序(SBS)深度测序来研究暴露于缺氧的培养血管内皮细胞(EC)中的miRNA,并使用生物信息学方法来分析全基因组范围内的缺氧响应性miRNA。在表达变化较大的miRNAs中,Let-7s和miR-103/107靶向Ago 1。这一结果表明,在缺氧条件下,内皮细胞中可能发生了“miRNA介导的翻译去抑制”机制。利用从高通量筛选和计算机模拟方法获得的这些数据,提出了两个具体的目的来检验在缺氧下,增加的Let-7s和miR-103/107下调Ago 1的假设。Ago 1的这种抑制降低了miRISC介导的miRNA靶向,因此上调了靶向mRNA,其编码响应缺氧的EC中的高度翻译的蛋白质。具体目标1将研究Ago 1调节的miRNA/mRNA靶向在缺氧应答的EC中的作用。我们将使用Ago 1交联免疫沉淀测序(CLIP-seq)来分析常氧和缺氧条件下EC中的miRISC相关miRNA及其mRNA靶点。特异性目的2将解释miRNA介导的翻译去抑制在培养的EC和小鼠后肢中的功能后果。具体而言,我们将在体外和体内操纵Let-7s和miR-103/107的表达。将在常氧和缺氧条件下检查miRISC介导的miRNA/mRNA靶向和mRNA编码的蛋白。阐明的机制将揭示内皮细胞响应缺氧时miRNA调节基因表达的机制见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John YJ Shyy其他文献
John YJ Shyy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John YJ Shyy', 18)}}的其他基金
AMPK Regulation of ACE2 in Endothelial Health and Disease
AMPK 在内皮健康和疾病中对 ACE2 的调节
- 批准号:
10568995 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
AMPK Regulation of ACE2 in Endothelial Health and Disease
AMPK 在内皮健康和疾病中对 ACE2 的调节
- 批准号:
10391055 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
Flow-Induced Endothelial Innate Immunity and Atherosclerosis Susceptibility
血流诱导的内皮先天免疫和动脉粥样硬化易感性
- 批准号:
9751360 - 财政年份:2016
- 资助金额:
$ 22.8万 - 项目类别:
Flow-Induced Endothelial Innate Immunity and Atherosclerosis Susceptibility
血流诱导的内皮先天免疫和动脉粥样硬化易感性
- 批准号:
9185542 - 财政年份:2016
- 资助金额:
$ 22.8万 - 项目类别:
The miRNA-mediated Translational De-suppression in Hypoxic Endothelium
缺氧内皮细胞中 miRNA 介导的翻译去抑制
- 批准号:
8534808 - 财政年份:2012
- 资助金额:
$ 22.8万 - 项目类别:
相似国自然基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
- 批准号:82300356
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
Tom1L1在胞内体蛋白分选机制中功能的研究
- 批准号:31171289
- 批准年份:2011
- 资助金额:56.0 万元
- 项目类别:面上项目
溶酶体依赖性TRAF2降解的机制
- 批准号:30971501
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
uORF-mediated Translational Control of Cardiac Transcription Factor Expression
uORF介导的心脏转录因子表达的翻译控制
- 批准号:
10659430 - 财政年份:2023
- 资助金额:
$ 22.8万 - 项目类别:
Contributions of tau-mediated translational dysregulation to pathogenesis and progression of fronto-temporal dementia
tau 介导的翻译失调对额颞叶痴呆发病机制和进展的影响
- 批准号:
10370091 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
Translational studies of cellular senescence as a regulator of doxorubicin-mediated arterial dysfunction
细胞衰老作为阿霉素介导的动脉功能障碍调节剂的转化研究
- 批准号:
10616523 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
C9orf72-mediated features, transcriptomic signatures, and translational studies for frontotemporal dementia and related disorders
C9orf72 介导的额颞叶痴呆和相关疾病的特征、转录组特征和转化研究
- 批准号:
10439173 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
Contributions of tau-mediated translational dysregulation to pathogenesis and progression of fronto-temporal dementia
tau 介导的翻译失调对额颞叶痴呆发病机制和进展的影响
- 批准号:
10554390 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
Translational studies of cellular senescence as a regulator of doxorubicin-mediated arterial dysfunction
细胞衰老作为阿霉素介导的动脉功能障碍调节剂的转化研究
- 批准号:
10450529 - 财政年份:2022
- 资助金额:
$ 22.8万 - 项目类别:
Assessing Transporter-Mediated Natural Product-Drug Interactions Using a Translational Research Approach
使用转化研究方法评估转运蛋白介导的天然产物-药物相互作用
- 批准号:
10315518 - 财政年份:2021
- 资助金额:
$ 22.8万 - 项目类别:
Assessing Transporter-Mediated Natural Product-Drug Interactions Using a Translational Research Approach
使用转化研究方法评估转运蛋白介导的天然产物-药物相互作用
- 批准号:
10477983 - 财政年份:2021
- 资助金额:
$ 22.8万 - 项目类别:
Investigating novel mechanisms of lipocalin-2 mediated cardiac dysfunction and their translational therapeutic potential
研究 lipocalin-2 介导的心脏功能障碍的新机制及其转化治疗潜力
- 批准号:
401512 - 财政年份:2019
- 资助金额:
$ 22.8万 - 项目类别:
Operating Grants
Translational studies on cerebrospinal fluid (CSF)-directed gene therapy for global neurometabolic brain disease
脑脊液(CSF)定向基因治疗全球神经代谢性脑疾病的转化研究
- 批准号:
10379947 - 财政年份:2019
- 资助金额:
$ 22.8万 - 项目类别: